Chief Medical Officer · Tenaya Therapeutics, Inc. (TNYA)

Whittemore Tingley

A named executive officer of Tenaya Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,174,644

Salary $521,192Stock awards $86,728

FY2024: $1,661,145

2nd of 2 named executive officers at Tenaya Therapeutics by FY2025 total.

2 named officers on file for Tenaya Therapeutics, FY2025

Whittemore Tingley’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tenaya Therapeutics’s whole pay program stands against its peers

  • Tenaya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TNYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Whittemore Tingley’s full pay file as a PDF — free

More than this page: up to 10 years of Whittemore’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Whittemore Tingley compensation by year

Tenaya Therapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Tenaya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024FY2025
Salary$371,000$402,947$455,609$475,000$504,919$521,192
Bonus$95,000$0$0$0$0$0
Stock awards$0$0$0$244,800$182,700$86,728
Option awards$0$1,146,080$1,668,932$491,242$871,890$385,071
Non-equity incentive$0$146,000$162,000$167,000$100,000$180,136
Pension and deferred compensation$0$0$0$0$0$0
All other$1,520$2,230$4,366$3,786$1,636$1,516
Total$467,520$1,697,258$2,290,907$1,381,827$1,661,145$1,174,644

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tenaya Therapeutics, Inc. DEF 14A filed April 16, 2026, accession 0001193125-26-158079, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tenaya Therapeutics, Inc. filed document, accession 0001193125-26-158079. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2026.

$468K
$1.7M
$2.3M
$1.4M
$1.7M
$1.2M
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU35,000$24,920—
RSU21,875$15,575—
RSU15,838$11,277—
RSU13,125$9,345—
Option5,875—$1.21
Option59,792—$1.21
Option116,459—$1.21
Option181,146—$1.21

Per the Outstanding Equity Awards at Fiscal Year-End table in Tenaya Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

8 Form 4 lines since the FY2025 proxy (filed April 16, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-17Sale—3,223$0.32259,850
2026-09-10Grant or award—49,000$0.00263,073
2026-09-10Grant or award derivative—293,000$0.00293,000
2026-08-17Sale—1,637$0.71219,860
2026-08-17Sale—1,637$0.71218,223
2026-08-17Sale—1,871$0.71216,352
2026-08-17Sale—2,279$0.71214,073
2026-05-18Sale—3,121$0.79215,497

The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Tenaya Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Faraz AliChief Executive Officer$1,881,396
Whittemore Tingley · this pageChief Medical Officer$1,174,644

The full Tenaya Therapeutics compensation record

free company brief

This page is one person within Tenaya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tenaya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Whittemore Tingley's compensation dossier · One-time report. No refunds.